APR 25, 2012
Amgen buys Turkish generics maker Mustafa Nevzat for USD 700 million
Haberturk – US biotechnology company Amgen has announced a deal to acquire 95.6...
RECENT SEARCHES
HIGHLIGHTED
RECOMMENDED RESULTS SHOW ALL
ENGLISH